Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

US Patent 11419942 · Granted Aug 23, 2022

Estimated economic value: $405,584,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for silencing UGT1a1 gene expression2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Methods for the treatment of trinucleotide repeat expansion disorders associated2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
Extrahepatic delivery2025
Extrahepatic delivery2025